7
Participants
Start Date
December 16, 2015
Primary Completion Date
January 10, 2017
Study Completion Date
February 7, 2017
PF-06372865
Single dose
Placebo
Placebo for PF-06372865 and placebo for lorazepam
Lorazepam
2 mg single oral dose
New York University Comprehensive Epilepsy Center, New York
Clinical and Translational Research Center, Philadelphia
Hospital of the Univ of PA Pharmacy Service, Philadelphia
University of Pennsylvania, Philadelphia
Thomas Jefferson University Comprehensive Epilepsy Center, Philadelphia
Thomas Jefferson University Hospital EEG lab, Philadelphia
Thomas Jefferson University Investigational Drug Service, Philadelphia
General Clinical Research Center (GCRC), Nashville
Vanderbilt University Epilepsy Clinic, Nashville
Vanderbilt University Hospital Pharmacy, Nashville
VU Department of Neurology, Nashville
Barnes Jewish Hospital, St Louis
Center for Advanced Medicine, St Louis
Washington University School of Medicine, St Louis
Consultants in Epilepsy & Neurology, PLLC, Boise
Johns Hopkins University Department of Neurology, Baltimore
Lead Sponsor
Pfizer
INDUSTRY